Contact
Clinical Professor, Faculty of Medicine & Dentistry - Medicine Dept
- mtaparia@ualberta.ca
- Phone
- (780) 407-1584
- Address
-
4-112H Clinical Sciences Building
11304 83 Ave NWEdmonton ABT6G 2G3
Overview
Area of Study / Keywords
About
Personal Statement:
My main areas of interest are bone marrow transplantation patients and rare diseases, particularly how we can improve outcomes through new drugs and therapies. Another related research interest is improving and standardizing treatment guidelines and protocols for blood disorders.
Hematologist Minakshi Taparia graduated from the Topiwala National Medical College, Mumbai University in Mumbai, India. She subsequently completed training in clinical and laboratory hematology in Australia and a clinical and laboratory hematology fellowship in the UK. She also has specialized training in bone marrow transplantation. She joined the Division of Hematology in 2006 and was promoted to clinical associate professor in 2016.
Leadership and Collaborations:
Dr. Taparia is a member of the Erdheim-Chester Disease Alliance and Histiocytic disorders. She was a member of the Residency Training Program for Hematology.
Clinical Interests
Dr. Taparia is a staff hematologist at the University of Alberta Hospital and the Cross Cancer Institute in Edmonton. At the Cross, she works with the Bone Marrow Transplantation Clinic and in a second clinic specializing in rare diseases such as Cutaneous T cell lymphomas (CTCL), Langerhans cell histiocytosis and mastocytosis. She is also doing a joint clinic with Dermatology for seeing patients with CTCL, this helps provide the best treatment strategies for these rare diseases in a better fashion. Her other area of interest is Myeloproliferative diseases. She is also part of both institutions’ Alberta Blood and Marrow Transplant Program. Dr. Taparia has led or been involved with developing treatment guidelines and protocols for several blood disorders including acute promyelocytic leukemia and post-transplant lymphoproliferative disorder.
Research
Dr. Taparia has been a member on several clinical research teams running clinical trials to look at drug effectiveness in treating disorders including acute myeloid leukemia. She is co-author of several articles published in such journals as Cytotherapy, Leukemia Research and Clin Transplant.
Teaching
Dr. Taparia has an interest in clinical teaching, is actively involved in teaching activities and has mentored hematology fellows in the past.
Featured Publications
Bilston L., Croden J., Taparia M., Karkhaneh M., Grossman J., Sun H.
European Journal of Haematology. 2022 August; 109 (2):129-137 10.1111/ejh.13779
Croden J., Bilston L., Taparia M., Grossman J., Sun H.
journal of thrombosis and hemostasis. 2022 March; 20 (3):671-683 10.1111/jth.15615
A Phase 1/2 Study of Single Agent Tagraxofusp, a First-in-Class CD123-Targeted Therapy, in Patients with Myelofibrosis That Is Relapsed/Refractory Following JAK Inhibitor Therapy
Blood (2021) 138 (Supplement 1): 140.. 2021 December;
Blood (2021) 138 (Supplement 1): 2318.. 2021 December; https://doi.org/10.1182/blood-2021-145344
Brandwein J.M., Hallett D., Karkhaneh M., Zhu N., Liew E., Bolster L., Hamilton M., Patterson J., Taparia M., Wu C., Van Slyke T., Bankar A., Saini L.
American Journal of Hematology. 2021 January; 96 (1):E17-E20 10.1002/ajh.26012
AMERICAN JOURNAL OF HEMATOLOGY. 2020 October; DOI: 10.1002/ajh.26012